Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Hackensack University Medical Center located at 30 Prospect Ave, Hackensack, NJ, 07601 & includes data from NPIs 1932200623, 1457456279
Dexur analyzed Q4 2017 (October to December 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Hackensack University Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,715 | 2,572 | ||||||||||
| Surgical | 1,028 | 999 | ||||||||||
| Non Surgical | 1,687 | 1,573 | ||||||||||
| Cardiovascular | 532 | 509 | ||||||||||
| Orthopedics | 366 | 362 | ||||||||||
| General Medicine | 328 | 289 | ||||||||||
| General Surgery | 253 | 236 | ||||||||||
| Urology | 247 | 241 | ||||||||||
| Pulmonology | 241 | 222 | ||||||||||
| Gastroenterology & Endocrinology | 205 | 199 | ||||||||||
| Neurology | 185 | 169 | ||||||||||
| Oncology & Hematology | 162 | 154 | ||||||||||
| Psychiatry & Mental Disorders | 74 | 71 | ||||||||||
| Spine | 46 | 46 | ||||||||||
| Colorectal | 39 | 38 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 22 | 21 |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Cardiac Defibrillator Implant | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Major Cardiovascular Procedures | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Medical Back Problems |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Complications Of Treatment |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| Major Chest Procedures | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
| Other Digestive System O.R. Procedures |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Male Pelvic Procedures | ||||||||||||
| DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Trauma | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| Cholecystectomy | ||||||||||||
| Disorders Of Pancreas Except Malignancy |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Traumatic Stupor And Coma, Coma < 1 Hour | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Respiratory Neoplasms | ||||||||||||
| DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Digestive Malignancy | ||||||||||||
| DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| Red Blood Cell Disorders |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Alcohol/Drug Abuse Or Dependence | ||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cervical Spinal Fusion | ||||||||||||
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New Jersey Total Hospitalizations (Oct 2017 to Dec 2017) | New Jersey Total Hospitalizations After Exclusion | New Jersey Total Users | New Jersey SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procedures For Obesity | ||||||||||||
| DRG 621: O.R. PROCEDURES FOR OBESITY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |